53(top 2%)
papers
2.1K(top 1%)
citations
27(top 1%)
h-index
46(top 1%)
g-index
54
all documents
2.2K
doc citations
623
citing journals

Top Articles

#TitleJournalYearCitations
1The Warburg Effect 97 Years after Its DiscoveryCancers2020153
2Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activationHepatology2011108
3Dual-Specificity Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase–Mediated Control of Growth in Human Hepatocellular CarcinomaCancer Research2008107
4Chemoprevention of hepatocarcinogenesisAlcohol200295
5SKP2 and CKS1 Promote Degradation of Cell Cycle Regulators and Are Associated With Hepatocellular Carcinoma PrognosisGastroenterology200995
65′-Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxicationJournal of Hepatology200193
7Role of HSP90, CDC37, and CRM1 as modulators of P16INK4Aactivity in rat liver carcinogenesis and human liver cancerHepatology200587
8Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCCGut200978
9Prognostic markers and putative therapeutic targets for hepatocellular carcinomaMolecular Aspects of Medicine201075
10Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosisInternational Journal of Cancer200773
11Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progressionHepatology201273
12S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancersHepatology201270
13Genetic Alterations in Liver Carcinogenesis: Implications for New Preventive and Therapeutic StrategiesCritical Reviews in Oncogenesis200065
14Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesisHepatology200263
15Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cellsCarcinogenesis200359
16Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human diseaseCarcinogenesis200854
17Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53Hepatology201153
18Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predispositionBiochimica Et Biophysica Acta: Reviews on Cancer200649
19Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 ActivityCancer Research200949
20Genetic and Epigenetic Control of Molecular Alterations in Hepatocellular CarcinomaExperimental Biology and Medicine200946
21Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular CarcinomaReviews on Recent Clinical Trials200743
22Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?Annals of Translational Medicine201539
23Ras‐driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic controlInternational Journal of Cancer200838
24Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotypeJournal of Hepatology201136
25S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytesHepatology201035
26Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible wistar rat strain199934
27S-Adenosylmethionine Regulates Apurinic/Apyrimidinic Endonuclease 1 Stability: Implication in HepatocarcinogenesisGastroenterology200931
28An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysisCellular Oncology (Dordrecht)201230
29Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular CarcinomaMedicina (Lithuania)201929
30Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF- B and Mat1A genes in the early stages of rat liver carcinogenesisCarcinogenesis200428
31Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparisonBiochimica Et Biophysica Acta: Reviews on Cancer201227
32Polygenic control of hepatocarcinogenesis in Copenhagen × F344 ratsInternational Journal of Cancer200426
33Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinomaTranslational Gastroenterology and Hepatology201823
34Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the ratHepatology199822
35Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human diseaseOncotarget201620
36The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the diseaseInternational Journal of Cancer201019
37Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strainHepatology200118
38MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genesOncotarget201918
39S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic AgentCells202218
40Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesisCancer Research200217
41Phenotypic reversion of rat neoplastic liver nodules is under genetic controlInternational Journal of Cancer200316
42Genetic control of resistance to hepatocarcinogenesis by the mouseHpcr3locusHepatology200816
43Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cellsFree Radical Biology and Medicine201913
44Implication of Bcl-2 family genes in basal and d-amphetamine–induced apoptosis in preneoplastic and neoplastic rat liver lesionsHepatology200012
45Mapping a Sex Hormone–Sensitive Gene Determining Female Resistance to Liver Carcinogenesis in a Congenic F344.BN-Hcs4 RatCancer Research200610
46Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/β-catenin pathway and progression of early lesions in the ratCarcinogenesis200710
47HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the ElderlyCancers20216
48Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinomaAnnals of Translational Medicine20165
49New insights on the role of epigenetic alterations in hepatocellular carcinomaJournal of Hepatocellular Carcinoma20144
50Sulfatase 1: a new Jekyll and Hyde in hepatocellular carcinoma?Translational Gastroenterology and Hepatology20163